[1] Wang J, Wang Y, Xu X, et al.Use of various doses of S+ketamine in treatment of depression and pain in cervical carcinoma patients with mild/moderate depression after laparoscopic total hyterectomy [J]. Med Sci Monit, 2020,22,26:e92208.DOI:10.12659/MSM.922028.
[2] Brenna CTA, Goldstein BI, Zarate, Jr CA , et al. Repurposing general anesthetic drug to treat depression: a new frontier for anesthesiologists in neuropsychiatric care [J].Anesthesiology,2024,141(2):222-236. DOI: 10.1097/ALN.0000000000005037.
[3] Berman RM, Capiello A,Anand A, et al. Antidepressant effects of Ketamine in depressed patients. Biol Psychiatry,2000,47(4):351-354. DOI:10.1016/S0006-3223(99)00230-9.
[6] Wang M, Xiong H, Sheng K, et al. Perioperative administration of pregabalin and esketamine to prevent chronic pain after breast cancer surgery : a randomized controlled trial [J]. Drug Des Devolop Ther, 2023,17(6):1699-1706. DOI:10.2147/DDDT.S413273.
[7] Lei Y,Liu H, Xia F, et al. Effects of esketamine on acute and Chronic pain after thoracoscopy pulmonary surgery under general anesthesia: a multicenter-prospective, randomized, double-blind and Controlled trail [0L]. Frontier Med, 2021, 8(1-8). DOI:10.3389/ fmed.2021.693594.
[9] Luscher B, Shen Q, Sahir N. The GABA ergic deficithypothesis of major depressive disorder [J]. Mol Psychiatry, 2011,16(4):383-406. DOI:10,1038/mp.2010.120.
[10] Riggs LM, Gould TD. Ketamine and the future of rapid-acting antidepressants [J].Annu Rev Clin Psychol, 2021,17: 207-231, DOI:10.1146/annurev-clinpsy-072120-014126
[11] Hess EM,Riggs LM, Michaelides M, et al. Mechanisms of Ketamine and its metabolites as antidepressants [J].Biochem Pharmacol, 2022,197:114892.DOI:10.1016/j.bcp.2021.114892.
[12] Daly EJ, Trivedi MH, Janik A, et al. Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: a randomized clinical trial [OL].JAMA Psychiatry, 2019.06.05. DOI:10.1001/jama psychiatry.2019.1189